Fumio Shimojo

Title: Fumio Shimojo: Innovator in Sustained-Release Formulations

Introduction

Fumio Shimojo is a prominent inventor based in Kawanishi, Japan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of sustained-release technologies. With a total of 16 patents to his name, Shimojo's work has had a considerable impact on drug delivery systems.

Latest Patents

Among his latest patents, Shimojo has developed a sustained-release formulation that includes a solid dispersion composition comprising a tricyclic compound or a pharmaceutically acceptable salt. This formulation is designed to enhance the delivery of medications by utilizing a mixture of water-soluble and water-insoluble polymers along with an excipient. Another notable patent involves a sustained-release formulation containing tacrolimus, which is crucial for preventing organ or tissue rejection in transplant patients. This formulation allows for the controlled release of tacrolimus over a period of 0.7 to 15 hours, ensuring effective therapeutic levels are maintained.

Career Highlights

Fumio Shimojo has worked with several notable companies in the pharmaceutical industry, including Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH. His experience in these organizations has allowed him to refine his expertise in drug formulation and delivery systems.

Collaborations

Shimojo has collaborated with esteemed colleagues such as Satoshi Ueda and Rinta Ibuki, contributing to the advancement of pharmaceutical innovations.

Conclusion

Fumio Shimojo's work in sustained-release formulations exemplifies the importance of innovation in the pharmaceutical industry. His patents and collaborations continue to influence the development of effective drug delivery systems, showcasing his commitment to improving patient care.